Cervical cancer is the fourth most common cancer among women worldwide. In India, where it is the second most common, it ...

Joining a clinical trial for cervical cancer opens the door to new treatments that could have life-changing effects.

as a monotherapy for the treatment of adult patients with second-line recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy. The approval means ...

The Federal Capital Territory Administration (FCTA) has acquired its first colposcopy machine, marking a significant step in combating cervical cancer and improving health outcomes in the region ...

Cervical cancer is caused by human papillomavirus HPV and has become a major health concern Read this article to know ...

Cervical cancer is a major health issue for Indian women, primarily caused by HPV. Key symptoms include abnormal bleeding and ...

A cervical cancer drug may elevate the risk of developing ocular surface disease, such as conjunctival scarring and infectious keratitis.

As one of the leading causes of death worldwide, cancer and its many types have cut many lives short -- some of whom were ...

In Europe, meanwhile, Regeneron’s PD-1 inhibitor Libtayo (cemiplimab) is indicated as a second-line therapy for recurrent or advanced cervical cancer, regardless of PD-L1 expression status, ...

Dominique Johnson, who had worked for the Internal Revenue Service for 15 years, died on Jan. 30 at the age of 40 after an ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...